Skip to main content
. 2017 Jul 18;8(34):56158–56167. doi: 10.18632/oncotarget.19341

Figure 3. Molecular interactions between Imatinib and KIT mutants.

Figure 3

(Left) Equilibrated MD snapshot of the Δ574–580 KIT mutant receptor in complex with Imatinib. The image is a zoomed view of the receptor binding site. The ligand is portrayed as sticks-and-balls and colored by element (C, gray; N, blue; O, red), hydrogen atoms being omitted for clarity. The protein residues mainly involved in the interaction with the inhibitor are highlighted as colored sticks and labeled. H-bonds interactions are shown as dotted black lines. (Right) Comparison of per-residue binding energy decomposition for Imatinib in complex with Δ574–580, Δ559, and T670I KIT mutant receptors.